Skip to main content
Premium Trial:

Request an Annual Quote

Genomics One Seeks to Acquire Canadian Shop s Proteomics Assets, Assumes CA$175K in Debt

NEW YORK, Nov. 19 (GenomeWeb News) - Genomics One has acquired from Solidarity Fund QFL a secured debt of CA$175,000 ($147,717) against Dephy Technologies, a Montreal-based proteomics company that recently filed for bankruptcy protection and ceased its activities.

 

Under the agreement, Genomics One will pay CA$175,000 and issue 20,000 common shares from its capital stock in exchange for the debt, plus accrued interest.

 

"Genomics One's intent in completing this deal was to be able to acquire all the tangible and intangible assets of Dephy which include equipment, completed instruments, work in process, intellectual property, and know-how," Suzanne Lebel, president and CEO of Genomics One, said in a statement. "Through this acquisition, Genomics One has become the only secured creditor of Dephy."

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.